原著論文1
Taguwa S., Kambara H., Omori H., et al.
Co-chaperone activity of human butyrate-induced transcript 1 facilitates hepatitis C virus replication through an Hsp90-dependent pathway.
J. Virol.
, 83
, 10427-10436
(2009)
原著論文2
Kukihara H., Moriishi K., Taguwa S.,et al.
Human VAP-C negatively regulates hepatitis C virus propagation.
J. Virol.
, 83
, 7959-7969
(2009)
原著論文3
Itose I., Kanto T., Kakita N., et al.
Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.
J. Viral. Hepat.
, 16
, 846-852
(2009)
原著論文4
Kohga K., Takehara T., Tatsumi T., et al.
Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Cancer Res.
, 69
, 8050-8057
(2009)
原著論文5
Kumagai Y., Kumar H., Koyama S., et al.
TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells.
J. Immunol.
, 182
, 3960-3964
(2009)
原著論文6
Matsushita K., Takeuchi O., Standley D.M., et al.
Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay.
Nature
, 458
, 1185-1190
(2009)
原著論文7
Kawagoe T., Takeuchi O., Takabatake Y., et al.
TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis.
Nat. Immunol.
, 10
, 965-972
(2009)
原著論文8
Satoh T., Kato H., Kumagai Y., et al.
LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses.
Proc Natl Acad Sci U S A.
, 105
, 1512-1517
(2010)
原著論文9
Shigemoto, T., Kageyama, M., Hirai, R., et al.
Identification of loss of function mutations in human genes encoding RIG-I and mda5: Implications for resistance to type I diabetes.
J. Biol. Chem.
, 284
, 13348-13354
(2009)
原著論文10
Takahasi, K., Kumeta, H., Tsuduki, N., et al.
Solution Structures of MDA5 and LGP2 C-terminal Domains: Identification of the RNA Recognition Loop in RIG-I Like Receptors.
J. Biol. Chem.
, 284
, 17465-17474
(2009)
原著論文11
Kuroki M., Ariumi Y., Ikeda M., et al.
Arsenic trioxide inhibits hepatitis C virus RNA replication through modulation of the glutathione redox system and oxidative stress.
J. Virol.
, 83
, 2338-2348
(2009)
原著論文12
Yano M., Ikeda M., Abe K., et al.
Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine Oxidative stress induces anti-hepatitis C virus status via the activation of extracellular signal-regulated kinase.
Hepatology
, 50
, 678-688
(2009)
原著論文13
Kawai Y., Ikeda M., Abe K., et al.
Development of an HCV relapse model using genome-length HCV RNA-harboring cells possessing the IFN-a-resistance phenotype.
Hepatol. Res.
, 39
, 898-909
(2009)
原著論文14
Ikeda M., Mori K., Ariumi Y., et al.
Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon-a.
FEBS Letters
, 583
, 1434-1438
(2009)
原著論文15
Hussein H.A., Shimotohno K., and Hijikata M.
3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV.
BBRC
, 379
, 330-334
(2009)
原著論文16
Hussein H.A., Qi Y., Atsuzawa K., et al.
Strain-dependent viral dynamics and virus cell interactions observed in a novel in vitro system supporting the life cycle of blood borne HCV.
Hepatology
, 50
, 689-696
(2009)
原著論文17
Machida K., Tsukiyama-Kohara K., Kohara M., et al.
Disruption of IFN signaling and HCV synergistically enhance lymphoproliferation through type II CD95 and interleukins.
Gastroenterology
, 137
, 285-296
(2009)
原著論文18
Amako Y., Tsukiyama-Kohara K., Kohara M., et al
Pathogenesis of hepatitis C virus infection in Tupaia belangeri.
J. Virol.
, 84
, 303-311
(2010)
原著論文19
Hara H., Aizaki H., Matsuda M., et al.
Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein.
J. Virol.
, 83
, 5137-5147
(2009)
原著論文20
Suzuki R., Moriishi K., Fukuda K., et al.
Proteasomal Turnover of Hepatitis C Virus Core Protein Is Regulated by Two Distinct Mechanisms: a Ubiquitin-Dependent Mechanism and a Ubiquitin-Independent but PA28-Dependent Mechanism.
J. Virol.
, 83
, 2389-2392
(2009)
